| 产品名称 | Novocib E-Nov3 | Recombinant Deoxycytidine Kinase 脱氧胞苷激酶 |
|---|---|
| 目录号 | E-Nov3 |
| 别名 | 脱氧胞苷激酶 |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| E-Nov3 | 500 mUnits; 2 Units | 咨询 | 咨询 |
Novocib E-Nov3 | Recombinant Deoxycytidine Kinase 脱氧胞苷激酶
品名：Recombinant Deoxycytidine Kinase
中文名称：脱氧胞苷激酶
货号：E-Nov3
规格：500 mUnits；2 Units
品牌：Novocib
产品描述
NOVOCIB's human deoxycytidine kinase is an active and purified protein of 33kDa cloned by RT-PCR amplification of mRNA extracted from human hepatoma cells and expressed in E.coli.
Deoxycytidine kinase is responsible for the phosphorylation and activation of numerous nucleoside analogs used to treat cancer (e.g. cytarabine, gemcitabine, cladribine, and fludarabine) including nucleoside analogs of non-physiological L-chirality (e.g. 3TC, lamivudine, anti-HIV, and anti-hepatitis B agent).
